Page last updated: 2024-09-05

sb 203580 and Injuries, Radiation

sb 203580 has been researched along with Injuries, Radiation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, L; He, N; Ji, K; Liu, Q; Liu, Y; Wang, J; Wang, Q; Wang, Y; Xiao, C; Xu, C; Zhang, M	1

Other Studies

1 other study(ies) available for sb 203580 and Injuries, Radiation

Article	Year
Atractylenolide II prevents radiation damage via MAPKp38/Nrf2 signaling pathway. Biochemical pharmacology, 2020, Volume: 177 Topics: Animals; Antioxidants; Cell Line; Gene Expression Regulation; Humans; Imidazoles; Keratinocytes; Lactones; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Pyridines; Radiation Injuries; Radiation-Protective Agents; Radiation, Ionizing; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction	2020

Article

Year

Atractylenolide II prevents radiation damage via MAPKp38/Nrf2 signaling pathway.

Biochemical pharmacology, 2020, Volume: 177

Topics: Animals; Antioxidants; Cell Line; Gene Expression Regulation; Humans; Imidazoles; Keratinocytes; Lactones; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Pyridines; Radiation Injuries; Radiation-Protective Agents; Radiation, Ionizing; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction

2020